Table 2.
Clinical Syndromes and Tumor Characteristics by Tumor Location
| Anterior | Middle | Posterior | Overlapping (AM/MP/AMP) |
p-value | |
|---|---|---|---|---|---|
| Patient Demographics | |||||
| Total (n, %) | 11 (22) | 7 (14) | 27 (53) | 6 (12) | |
| Female (n, %) | 10 (91) | 4 (57) | 23 (85) | 4 (67) | 0.2325 |
| Median Age (yrs, range) | 63 (48–74) | 51 (40–77) | 62 (37–84) | 69 (46–90) | 0.5326* |
| Tumor Demographics | |||||
| Largest Tumor Diameter (cm, range) | 1.8 (0.8–3.2) | 3 (2.6–3.5) | 3.8 (1.1–5.9) | 4.0 (2.8–6.2) | 0.0003* |
| Tumor Size ≥3 cm (n, %) | 1 (9) | 4 (57) | 17 (63) | 5 (83) | 0.0079 |
| Tumor Size < 3 cm (n, %) | 10 (91) | 3 (43) | 10 (37) | 1 (17) | |
| WHO Grade I (n, %) | 11 (100) | 7 (100) | 26 (96) | 6 (100) | 0.8238 |
| WHO Grade II (n, %) | 0 (0) | 0 (0) | 1 (4) | 0 (0) | |
| Clinical Symptoms (n, %) | |||||
| Hydrocephalus | 0 (0) | 0 (0) | 10 (37) | 3 (50) | 0.0190 |
| Headache | 0 (0) | 2 (29) | 17 (63) | 3 (50) | 0.0039 |
| Ataxia | 0 (0) | 2 (29) | 10 (37) | 2 (33) | 0.1376 |
| Vertigo | 1 (9) | 1 (14) | 15 (55) | 2 (33) | 0.0265 |
| Cranial Neuropathy | |||||
| Any | 10 (91) | 6 (86) | 10 (37) | 5 (83) | 0.0034 |
| Extraocular (III, IV, VI) | 0 (0) | 0 (0) | 1 (4) | 1 (17) | 0.3442 |
| Trigeminal (V) | 10 (91) | 3 (43) | 2 (7) | 0 (0) | < 0.0001 |
| Facial (VII) | 0 (0) | 1 (14) | 0 (0) | 0 (0) | 0.0932 |
| Auditory (VIII) | 0 (0) | 4 (57) | 9 (33) | 5 (83) | 0.0035 |
p-value for Pearson’s Chi-Square unless noted
*
p-value for Wilcoxon test